FTO Human shRNA Plasmid Kit (Locus ID 79068)
CAT#: TL308064
FTO - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 7 publications. |
Product images
CNY 1,999.00
CNY 2,700.00
CNY 4,070.00
Specifications
Product Data | |
Product Name | FTO Human shRNA Plasmid Kit (Locus ID 79068) |
Locus ID | 79068 |
UniProt ID | Q9C0B1 |
Synonyms | ALKBH9; BMIQ14; GDFD |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | FTO - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 79068). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_001080432, NM_001080432.1, NM_001080432.2, BC001284, BC003583, BC030798, BC132892, BC137091, BC148442, BC153032, NM_001363905, NM_001363988, NM_001363891, NM_001363894, NM_001363896, NM_001363897, NM_001363898, NM_001363899, NM_001363900, NM_001363901, NM_001363903, NR_156761, NM_001080432.3 |
Summary | This gene is a nuclear protein of the AlkB related non-haem iron and 2-oxoglutarate-dependent oxygenase superfamily but the exact physiological function of this gene is not known. Other non-heme iron enzymes function to reverse alkylated DNA and RNA damage by oxidative demethylation. Studies in mice and humans indicate a role in nervous and cardiovascular systems and a strong association with body mass index, obesity risk, and type 2 diabetes. [provided by RefSeq, Jul 2011] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (7)
The use of this RNAi has been cited in the following citations: |
---|
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
,null,
Nature Communications
,PubMed ID 33741917
[FTO]
|
FTO-Dependent N6-Methyladenosine Modifications Inhibit Ovarian Cancer Stem Cell Self-Renewal by Blocking cAMP Signaling
,Huang, H;Wang, Y;Kandpal, M;Zhao, G;Cardenas, H;Ji, Y;Chaparala, A;Tanner, EJ;Chen, J;Davuluri, RV;Matei, D;,
Cancer Res.
,PubMed ID 32606006
[FTO]
|
FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell
,Relier, S;Ripoll, J;Guillorit, H;Amalric, A;Boissiere, F;,
bioRxiv
[FTO]
|
The m6A eraser FTO facilitates proliferation and migration of human cervical cancer cells
,Zou, D;Dong, L;Li, C;Yin, Z;Rao, S;Zhou, Q;,
Cancer Cell Int.
,PubMed ID 31827395
[FTO]
|
R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling
,Su, R;Dong, L;Li, C;Nachtergaele, S;Wunderlich, M;Qing, Y;Deng, X;Wang, Y;Weng, X;Hu, C;Yu, M;Skibbe, J;Dai, Q;Zou, D;Wu, T;Yu, K;Weng, H;Huang, H;Ferchen, K;Qin, X;Zhang, B;Qi, J;Sasaki, AT;Plas, DR;Bradner, JE;Wei, M;Marcucci, G;Jiang, X;Mulloy, JC;Jin, J;He, C;Chen, J;,
Cell
,PubMed ID 29249359
[FTO]
|
Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N6-Adenosine Methylation To Promote Lytic Replication
,Ye, F;Chen, ER;Nilsen, TW;,
J. Virol.
,PubMed ID 28592530
[FTO]
|
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N(6)-Methyladenosine RNA Demethylase
,Li, Z;Weng, H;Su, R;Weng, X;Zuo, Z;Li, C;Huang, H;Nachtergaele, S;Dong, L;Hu, C;Qin, X;Tang, L;Wang, Y;Hong, GM;Huang, H;Wang, X;Chen, P;Gurbuxani, S;Arnovitz, S;Li, Y;Li, S;Strong, J;Neilly, MB;Larson, RA;Jiang, X;Zhang, P;Jin, J;He, C;Chen, J;,
Cancer Cell
,PubMed ID 28017614
[FTO]
|
Documents
Product Manuals |
FAQs |
SDS |